DYNC1LI1

Cytoplasmic dynein 1 light intermediate chain 1 · Q9Y6G9 · DYNC1LI1 on Sugi Atlas →

0 patent compounds predicted against DYNC1LI1, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to DYNC1LI1 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Cornelia De Lange Syndrome: Assessing Positive Effects of Lithium Treatment PHASE2/PHASE3RECRUITING
Pembrolizumab (MK-3475) in MM Patients With Residual Disease PHASE2COMPLETED
Sirolimus Treatment in Patients With Autosomal Dominant Polycystic Kidney Disease: Renal Efficacy and Safety PHASE2COMPLETED
Functional Studies of Novel Genes Mutated in Primary Ciliary Dyskinesia II: Genotype to Phenotype EARLY_PHASE1COMPLETED
Diagnosis of Primary Ciliary Dyskinesia nanCOMPLETED
Genetic Study of Patients With Primary Ciliary Dyskinesia nanCOMPLETED
Characterizing the Upper Airway Manifestations in Primary Ciliary Dyskinesia and Primary Immunodeficiencies nanCOMPLETED
Classification, Functional Stratification and Biomarkers in Ciliopathy (CILLICORIRCM) nanCOMPLETED
NIOX VERO Nasal Application in Primary Ciliary Dyskinesia nanCOMPLETED
Genetics of Primary Ciliary Dyskinesia nanCOMPLETED
Early Detection and Characterization of Primary Ciliary Dyskinesia nanUNKNOWN
Pathogenesis of Primary Ciliary Dyskinesia (PCD) Lung Disease nanRECRUITING
Whole-genome Sequencing Study in Patients With Diminished Ovarian Reserve nanUNKNOWN
Biomarker Research in Inherited Movement Disorders nanRECRUITING
Genetic Studies of Strabismus, Congenital Cranial Dysinnervation Disorders (CCDDs), and Their Associated Anomalies nanRECRUITING
Assessing the Polygenic Burden of Rare Disruptive Mutations in Parkinson's Disease nanUNKNOWN
Mapping Disease Pathways for Biliary Atresia nanRECRUITING
PCD New Gene Discovery nanCOMPLETED
Clinical Outcome Study for Dysferlinopathy nanUNKNOWN
Quantitative Assessment of the Etiologies of Megalencephaly Associated With a Detectable Tumor Risk nanNOT_YET_RECRUITING
The Impact of Mitochondrial Dysfunction on Human Bone Cell Metabolism and Remodelling nanACTIVE_NOT_RECRUITING
A Study Providing Genetic Testing to Find Those Who May Have Primary Ciliary Dyskinesia for Potential Clinical Trials nanACTIVE_NOT_RECRUITING
Peripheral Neurofilament Levels and Amyotrophic Lateral Sclerosis nanCOMPLETED
Mapping Novel Disease Genes for Dilated Cardiomyopathy nanCOMPLETED
Characteristics of Nondystrophic Myotonias nanCOMPLETED
Genotype-Phenotype Correlations of Late Infantile Neuronal Ceroid Lipofuscinosis nanCOMPLETED
Gene Mutations and Rescue in Human Congenital Diaphragmatic Hernia nanUNKNOWN
Autophagy in Systemic Lupus Erythematosus nanUNKNOWN
Nuclear Myosin VI - a Therapeutic Target in Breast Cancer nanUNKNOWN
Muscle Tissue Bank for Muscular Dystrophy nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a DYNC1LI1 binder may also engage these)

ProteinNameSimilarity
Q8R1Q8 1.000 Q8R1Q8 →
Q9QXU8 1.000 Q9QXU8 →
Q90828 0.994 Q90828 →
Q6PDL0 0.986 Q6PDL0 →
DYNC1LI2 Cytoplasmic dynein 1 light intermediate chain 2 0.986 landscape →
Q5RE09 0.985 Q5RE09 →
Q62698 0.983 Q62698 →
E1C065 0.979 E1C065 →
Q5R539 0.978 Q5R539 →
Q0V989 0.978 Q0V989 →
D3ZYR1 0.977 D3ZYR1 →
O43815 0.977 O43815 →
B5DDX6 0.977 B5DDX6 →
Q5EY87 0.976 Q5EY87 →
O08816 0.975 O08816 →
A4IFB1 0.975 A4IFB1 →
B5X165 0.975 B5X165 →
Q6GQN0 0.974 Q6GQN0 →
Q4R5P6 0.974 Q4R5P6 →
Q7PQ25 0.974 Q7PQ25 →
Q9DBA9 0.974 Q9DBA9 →
Q5PQS6 0.974 Q5PQS6 →
Q6DHL7 0.974 Q6DHL7 →
Q5FWH3 0.973 Q5FWH3 →
O60271 0.973 O60271 →
Q58A65 0.973 Q58A65 →
Q05AW9 0.973 Q05AW9 →
Q66I22 0.973 Q66I22 →
Q6NXC0 0.973 Q6NXC0 →
Q5ZL23 0.972 Q5ZL23 →